162 related articles for article (PubMed ID: 30558510)
1. Expression of the Short Form of RON/STK in Feline Mammary Carcinoma.
Maniscalco L; Guil-Luna S; Iussich S; Gattino F; Trupia C; Millan Y; de Las Mulas JM; Cespedez RS; Saeki K; Accornero P; De Maria R
Vet Pathol; 2019 Mar; 56(2):220-229. PubMed ID: 30558510
[TBL] [Abstract][Full Text] [Related]
2. Feline STK gene expression in mammary carcinomas.
De Maria R; Maggiora P; Biolatti B; Prat M; Comoglio PM; Castagnaro M; Di Renzo MF
Oncogene; 2002 Mar; 21(11):1785-90. PubMed ID: 11896610
[TBL] [Abstract][Full Text] [Related]
3. Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational study.
Dagher E; Abadie J; Loussouarn D; Fanuel D; Campone M; Nguyen F
BMC Vet Res; 2019 Jan; 15(1):25. PubMed ID: 30630524
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer.
Dagher E; Royer V; Buchet P; Abadie J; Loussouarn D; Campone M; Nguyen F
BMC Cancer; 2019 Dec; 19(1):1267. PubMed ID: 31888566
[TBL] [Abstract][Full Text] [Related]
5. Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas.
Figueira AC; Gomes C; de Oliveira JT; Vilhena H; Carvalheira J; de Matos AJ; Pereira PD; Gärtner F
BMC Vet Res; 2014 Nov; 10():270. PubMed ID: 25424750
[TBL] [Abstract][Full Text] [Related]
6. Correlation of vascular endothelial growth factor expression to overall survival in feline invasive mammary carcinomas.
Millanta F; Lazzeri G; Vannozzi I; Viacava P; Poli A
Vet Pathol; 2002 Nov; 39(6):690-6. PubMed ID: 12450199
[TBL] [Abstract][Full Text] [Related]
7. Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas.
Maniscalco L; Millán Y; Iussich S; Denina M; Sánchez-Céspedes R; Gattino F; Biolatti B; Sasaki N; Nakagawa T; Di Renzo MF; de Las Mulas JM; De Maria R
BMC Vet Res; 2013 Apr; 9():80. PubMed ID: 23587222
[TBL] [Abstract][Full Text] [Related]
8. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
[TBL] [Abstract][Full Text] [Related]
9. Activation of AKT in feline mammary carcinoma: a new prognostic factor for feline mammary tumours.
Maniscalco L; Iussich S; de Las Mulas JM; Millán Y; Biolatti B; Sasaki N; Nakagawa T; De Maria R
Vet J; 2012 Jan; 191(1):65-71. PubMed ID: 21282070
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of HER-2 in feline invasive mammary carcinomas: an immunohistochemical survey and evaluation of its prognostic potential.
Millanta F; Calandrella M; Citi S; Della Santa D; Poli A
Vet Pathol; 2005 Jan; 42(1):30-4. PubMed ID: 15657269
[TBL] [Abstract][Full Text] [Related]
11. Expression and mutational status of RON in neoplastic lesions of the breast: analysis of MSP/RON signaling in ductal carcinoma in situ and invasive ductal carcinoma.
Ren X; Daa T; Yada N; Kashima K; Fujitomi Y; Yokoyama S
APMIS; 2012 May; 120(5):358-67. PubMed ID: 22515290
[TBL] [Abstract][Full Text] [Related]
12. HER2 Amplification Status in Feline Mammary Carcinoma: A Tissue Microarray-Fluorescence In Situ Hydridization-Based Study.
Muscatello LV; Di Oto E; Sarli G; Monti V; Foschini MP; Benazzi C; Brunetti B
Vet Pathol; 2019 Mar; 56(2):230-238. PubMed ID: 30384816
[TBL] [Abstract][Full Text] [Related]
13. Expression of mRNA of chemokine receptor CXCR4 in feline mammary adenocarcinoma.
Tanabe S; Nakadai T; Furuoka H; Oomachi T; Kobayashi Y; Omata Y; Koyama T; Hondo E; Uzuka Y; Sarashina T; Ducusin RJ; Shida T; Dorf ME
Vet Rec; 2002 Dec; 151(24):729-33. PubMed ID: 12509077
[TBL] [Abstract][Full Text] [Related]
14. Conditional deletion of β-catenin in mammary epithelial cells of Ron receptor, Mst1r, overexpressing mice alters mammary tumorigenesis.
Wagh PK; Zinser GM; Gray JK; Shrestha A; Waltz SE
Endocrinology; 2012 Jun; 153(6):2735-46. PubMed ID: 22474186
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression of claudin-2 is associated with high histological grade and metastasis of feline mammary carcinomas.
Flores AR; Rêma A; Carvalho F; Faustino A; Dias Pereira P
J Comp Pathol; 2014; 150(2-3):169-74. PubMed ID: 24220012
[TBL] [Abstract][Full Text] [Related]
16. CXCR4 expression in feline mammary carcinoma cells: evidence of a proliferative role for the SDF-1/CXCR4 axis.
Ferrari A; Petterino C; Ratto A; Campanella C; Wurth R; Thellung S; Vito G; Barbieri F; Florio T
BMC Vet Res; 2012 Mar; 8():27. PubMed ID: 22417013
[TBL] [Abstract][Full Text] [Related]
17. Mammary invasive micropapillary carcinoma in cats: clinicopathologic features and nuclear DNA content.
Seixas F; Palmeira C; Pires MA; Lopes C
Vet Pathol; 2007 Nov; 44(6):842-8. PubMed ID: 18039897
[TBL] [Abstract][Full Text] [Related]
18. Steroid hormone receptors in normal, dysplastic and neoplastic feline mammary tissues and their prognostic significance.
Millanta F; Calandrella M; Vannozzi I; Poli A
Vet Rec; 2006 Jun; 158(24):821-4. PubMed ID: 16782855
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical Expression Profiles of Cell Adhesion Molecules, Matrix Metalloproteinases and their Tissue Inhibitors in Central and Peripheral Neoplastic Foci of Feline Mammary Carcinoma.
Pisamai S; Rungsipipat A; Kunnasut N; Suriyaphol G
J Comp Pathol; 2017; 157(2-3):150-162. PubMed ID: 28942298
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer.
De Maria R; Olivero M; Iussich S; Nakaichi M; Murata T; Biolatti B; Di Renzo MF
Cancer Res; 2005 Feb; 65(3):907-12. PubMed ID: 15705889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]